((自动化翻译由路透提供,请见免责声明 ))
10月17日 - ** 药物开发商 Gritstone bio 股价盘前下跌 16.3% 至 5 美分
** 周三晚些时候,该公司表示,由于破产保护, (link),将裁员19%或25人。
** GRTS 预计将在第四季度因裁员一次性支出约 30 万美元。
** 公司于 10 月 10 日申请破产 (link)
** 公司普通股将于 10 月 22 日开市时暂停交易" - GRTS
** 截至上次收盘,股价累计下跌 97.1
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.